Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telemonitoring as a Tool for the Assessment of Treatment Effects of Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD)

NCT04428957 is registered in ClinicalTrials.gov with Medical University of Lodz as lead sponsor.

NCT NCT04428957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04428957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telemonitoring as a Tool for the Assessment of Treatment Effects of Connective Tissue Disease-associated Interstitial Lung Disease (TEL-CTD-ILD)
Lead sponsor
Medical University of Lodz
Phase
Not applicable
Overall status
Unknown status
Start date
February 11, 2020
Completion date
April 30, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue disease-associated interstitial lung disease, connective tissue diseases, interstitial lung disease